Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,754 | 2,892 | 2,618 | 4,468 | 5,513 |
| Receivables | 10,470 | 9,032 | 9,526 | 7,895 | 7,724 |
| TOTAL | $14,084 | $13,178 | $13,639 | $13,198 | $14,017 |
| Non-Current Assets | |||||
| PPE Net | 4,967 | 5,272 | 5,721 | 6,533 | 6,941 |
| Intangibles | 335 | 335 | 335 | 335 | 335 |
| Other Non-Current Assets | 5,854 | 6,148 | 6,437 | 6,721 | 7,001 |
| TOTAL | $11,156 | $11,755 | $12,493 | $13,589 | $14,277 |
| Total Assets | $25,240 | $24,933 | $26,132 | $26,787 | $28,294 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,854 | 5,235 | 5,800 | 4,756 | 4,536 |
| Accrued Expenses | 2,235 | 2,097 | 2,160 | 2,430 | 2,023 |
| Other current liabilities | 151 | 151 | 150 | 149 | 148 |
| TOTAL | $18,861 | $19,164 | $21,541 | $21,969 | $20,950 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,220 | 10,312 | 12,094 | 13,329 | 12,968 |
| Other Non-Current Liabilities | 5,698 | 6,101 | 6,494 | 6,876 | 7,251 |
| TOTAL | $5,698 | $6,101 | $6,494 | $6,876 | $7,251 |
| Total Liabilities | $24,559 | $25,265 | $28,035 | $28,845 | $28,201 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,819 | 13,594 | 13,594 | 13,594 | 13,594 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -82,552 | -83,280 | -84,593 | -84,484 | -81,954 |
| Other shareholders' equity | 292 | 292 | 292 | 292 | 292 |
| TOTAL | $681 | $-332 | $-1,903 | $-2,058 | $93 |
| Total Liabilities And Equity | $25,240 | $24,933 | $26,132 | $26,787 | $28,294 |